View Older Stories View More Recent Stories

Aug 25, 2020 04:01PM ReViral Raises $44 Million in Series C Financing
Aug 24, 2020 07:00AM Prelude Therapeutics Announces Closing of $50M Series C Financing
Aug 19, 2020 05:14PM Form SC 13G/A ESSA Pharma Inc. Filed by: ORBIMED ADVISORS LLC
Aug 18, 2020 04:32PM Form SC 13D Acutus Medical, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 18, 2020 07:00AM Ikena Oncology Appoints Dr. Sergio Santillana, MD, MSc, MBA as Chief Medical Officer
Aug 14, 2020 04:54PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2020 09:06PM Form 4 Acutus Medical, Inc. For: Aug 10 Filed by: ORBIMED ADVISORS LLC
Aug 12, 2020 07:00AM Ikena Oncology Announces Publication in Nature Communications of Preclinical Data Supporting the Therapeutic Potential of AHR Blockade
Aug 11, 2020 06:24PM Form 4 Inspire Medical Systems, For: Aug 07 Filed by: ORBIMED ADVISORS LLC
Aug 10, 2020 08:30AM Xtant Medical Announces Debt Restructuring
Aug 5, 2020 09:05PM Form 3 Acutus Medical, Inc. For: Aug 05 Filed by: ORBIMED ADVISORS LLC
Aug 5, 2020 04:05PM Natera Reports Second Quarter 2020 Financial Results
Aug 3, 2020 08:00AM PMV Pharma Closes $70 Million in Series D Financing
Jul 30, 2020 06:26PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Jul 28, 2020 06:02AM Form SC 13G Pandion Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jul 16, 2020 08:41PM Form 3 Pandion Therapeutics, For: Jul 16 Filed by: ORBIMED ADVISORS LLC
Jul 16, 2020 05:13PM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 13, 2020 04:21PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 10, 2020 11:55AM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 8, 2020 09:00AM Edgewise Therapeutics Appoints Abby H. Bronson, M.B.A., as Vice President, Patient Advocacy and External Innovation
Jul 7, 2020 06:01AM Form SC 13D Fusion Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Jul 1, 2020 05:31PM Form SC 13D/A TELA Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 30, 2020 09:20AM Sinovac Reports Unaudited First Quarter 2020 Financial Results
Jun 30, 2020 06:32AM Form SC 13D Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jun 26, 2020 06:03AM Form SC 13D Repare Therapeutics Inc. Filed by: ORBIMED ADVISORS LLC
Jun 25, 2020 08:01PM Form 3 Fusion Pharmaceuticals For: Jun 25 Filed by: ORBIMED ADVISORS LLC
Jun 23, 2020 09:37PM Form 4 Compass Therapeutics, For: Jun 19 Filed by: ORBIMED ADVISORS LLC
Jun 23, 2020 09:34PM Form 3 Compass Therapeutics, For: Jun 17 Filed by: ORBIMED ADVISORS LLC
Jun 22, 2020 09:00AM Ikena Oncology Presents New Preclinical Data Highlighting the Anti-Cancer Effects of TEAD Inhibition on the Hippo Signaling Pathway
Jun 18, 2020 09:35PM Form 3 Repare Therapeutics Inc. For: Jun 18 Filed by: ORBIMED ADVISORS LLC
Jun 17, 2020 09:00AM Edgewise Therapeutics Appoints Kirsten L. Gruis, M.D., M.S. as Chief Medical Officer
Jun 11, 2020 04:26PM Form SC 13D/A BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC
Jun 4, 2020 04:59PM Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC
May 27, 2020 07:00AM Q32 Bio Launches to Develop Novel Therapeutics Targeting Regulators of Innate and Adaptive Immunity
May 26, 2020 04:40PM Form SC 13D/A scPharmaceuticals Inc. Filed by: ORBIMED ADVISORS LLC
May 22, 2020 04:55PM Form SC 13D/A Turning Point Therapeuti Filed by: ORBIMED ADVISORS LLC
May 22, 2020 04:55PM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
May 22, 2020 07:00AM Keros Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results
May 22, 2020 07:00AM Keros Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results
May 20, 2020 05:28PM Form 4 Xtant Medical Holdings, For: May 06 Filed by: ORBIMED ADVISORS LLC
May 20, 2020 04:55PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
May 15, 2020 04:37PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 8, 2020 06:01AM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
May 7, 2020 07:00AM 9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition
May 6, 2020 06:11PM Natera (NTRA) Tops Q1 EPS by 11c, Revenues Beat
May 6, 2020 04:05PM Natera Reports First Quarter 2020 Financial Results
May 4, 2020 05:30PM 9 Meters Biopharma, Inc Announces the Closing of $22.5 Million Private Placement Funding
May 1, 2020 04:16PM Form SC 13D Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Apr 30, 2020 06:15PM 9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma
Apr 30, 2020 04:29PM Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F
View More Recent Stories View Older Stories